Zimmer Biomet

Warsaw, Indiana, USA  All United States companies → — Founded 1927
Healthcare Conglomerate Medical Device / Hardware
Orthopedics
Website Claim this company

Products

ROSA Knee System (with OptimiZe)
Zimmer Biomet
Surgical AI
The ROSA Knee System, powered by AI-driven OptimiZe technology, is an FDA-cleared robotic surgical assistant designed to enhance precision and personalization in total knee replacement procedures.
Contact for pricing

See all 1 product →

About Zimmer Biomet

Zimmer Biomet is a global leader in medical technology, dedicated to restoring mobility and improving the quality of life for patients worldwide. For physicians, the company offers an extensive portfolio of musculoskeletal healthcare solutions, primarily focused on orthopedic reconstructive products such as hip and knee implants, as well as products for sports medicine, biologics, extremities, trauma, spine, craniomaxillofacial, and dental applications. Their offerings are designed to support surgeons across the continuum of care, from pre-operative planning to intra-operative execution and post-operative recovery, aiming to enhance surgical precision, patient outcomes, and practice efficiency.

While not exclusively an AI company, Zimmer Biomet actively integrates advanced digital technologies, data analytics, and artificial intelligence into its platforms to provide intelligent solutions. For instance, their ZBEdge™ ecosystem combines connected technologies, data, and insights to support personalized patient care and optimize surgical workflows. This includes smart implants like Persona IQ, the world’s first and only smart knee cleared by the FDA, which provides objective data on range of motion and step count directly from the implant. These innovations empower physicians with actionable data and tools to make more informed decisions, streamline procedures, and potentially improve long-term patient satisfaction and functional recovery.

What Physicians Need to Know

Orthopedic Surgical Planning & Robotics
Zimmer Biomet specializes in AI-powered pre-operative planning and robotic-assisted surgery, particularly for hip and knee replacements. Their ROSAu00ae Knee system, for instance, uses AI to analyze pre-operative imaging and longitudinal data to generate patient phenotypes and recommend implant type and alignment philosophy. The ZBEdge platform integrates robotic and digital technologies to enhance surgical precision and patient outcomes.
Intra-operative Guidance & Efficiency
Their AI tools provide real-time intra-operative assistance. OrthoGrid Hip AIu00ae offers direct anterior hip surgeons intuitive tools for functional pelvic plane tracking, offset, and precise leg length and cup positioning, utilizing AI-powered fluoroscopic-assisted software. OrthoGrid Trauma AIu00ae provides real-time image analysis for Open Reduction and Internal Fixation (ORIF) procedures, correcting C-arm image distortion and confirming reduction and alignment. Omniu2122 Suite uses AI-based object recognition to automate manual tasks and timestamp key OR workflow milestones, optimizing procedural efficiency.
Post-operative Patient Monitoring & Prediction
Zimmer Biomet's WalkAIu2122 is a dynamic AI model that predicts post-operative gait speed recovery after hip or knee surgery, identifying patients who may deviate from typical recovery curves. This is integrated with the mymobilityu00ae Care Management Platform, which collects patient gait data via smartphones to provide personalized recovery insights.
Data-Driven Personalized Care
The ZBEdgeu00ae platform acts as an 'Agentic AI layer' that connects data across consumers, patients, and medical providers, breaking down data silos. This enables clinicians to create longitudinal views of the patient continuum and develop patient phenotypes for personalized care journeys. Zimmer Biomet has collected over 44 million days of patient data to feed these algorithms, augmenting decision-making and supporting surgical planning.
Operating Room Workflow Optimization
AI capabilities within Omniu2122 Suite are designed to optimize surgical workflow and procedural efficiency by automating manual tasks and streamlining technology. This includes automatically recognizing and timestamping workflow milestones, providing real-time metrics to guide surgical teams.
Physician Tip

For physicians, Zimmer Biomet's AI tools, particularly through the ZBEdge platform, offer actionable insights derived from extensive patient data, enabling more informed decision-making before, during, and after surgery. These tools aim to enhance surgical precision, personalize patient care plans, and predict recovery outcomes, potentially leading to improved patient satisfaction and reduced complications. The integration of robotics with AI, such as ROSA Knee with OptimiZe, helps surgeons deliver optimized alignment philosophies and can result in faster patient recovery and less physician stress. Furthermore, solutions like OrthoGrid Hip AI and Trauma AI streamline intra-operative procedures, saving time and improving reproducibility of outcomes. The focus on connecting data across the entire patient journey helps create a holistic view, empowering care teams to proactively address potential issues and tailor interventions.

Zimmer Biomet's AI framework is built on Microsoft Azure, demonstrating a robust and secure foundation for their digital health solutions. They are also actively collaborating with companies like Peritas AI, leveraging NVIDIA's Physical AI and accelerated computing, to explore agentic connected robotics for a more unified and intelligent operating room environment, aiming to orchestrate implants, robotics, instrumentation, and even humanoid robots seamlessly. This indicates a strategic approach to integrating advanced AI and robotics technologies to create a comprehensive and interconnected ecosystem for orthopedic care.

Products by Zimmer Biomet

1 product in the directory

ROSA Knee System (with OptimiZe)
Zimmer Biomet
Surgical AI
The ROSA Knee System, powered by AI-driven OptimiZe technology, is an FDA-cleared robotic surgical assistant designed to enhance precision and personalization in total knee replacement procedures.
Contact for pricing

What the Web Says

Zimmer Biomet generally receives mixed to positive reviews. Many users praise the quality and effectiveness of their medical devices, particularly in orthopedics. However, some employees express concerns about work-life balance, internal communication, and corporate culture.

Overall: Mixed

Strengths

  • High-quality and effective medical devices (orthopedics, dental)
  • Strong brand recognition and industry leadership
  • Good compensation and benefits for some roles
  • Opportunities for professional growth and learning
  • Impactful work in healthcare
  • Innovative product development

Limitations

  • Challenging work-life balance and long hours
  • Issues with internal communication and transparency
  • Bureaucratic processes and slow decision-making
  • High pressure sales environment
  • Inconsistent management quality across departments
  • Integration challenges post-merger

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers

Last updated: 2026-08-25

Videos

News, demos, and interviews about Zimmer Biomet.

Loading videos...

Videos load interactively. If none appear, search YouTube for Zimmer Biomet →

View all on YouTube

Press & Coverage

MedTech Dive
Zimmer Biomet sales force revamp going better than expected, CEO says
Zimmer Biomet's CEO announced that the company's transition to a fully dedicated sales force is progressing better than anticipated, leading to increased sales and earnings expectations for 2026. The restructuring involves shifting 2,500 U.S. sales personnel to dedicated specialists and focusing on higher-growth segments.
2026-08
PR Newswire
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
Zimmer Biomet will unveil new clinical and operational data and showcase its latest innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2026 Annual Meeting, with Chief Movement Officer Arnold Schwarzenegger as the Presidential Guest Speaker. The company will highlight its leadership in orthopedic implants and integrated digital and robotic technologies.
2026-02
PR Newswire
Zimmer Biomet Announces Second Quarter 2026 Financial Results
Zimmer Biomet reported its financial results for the second quarter of 2026, with details on net sales, earnings per share, and other financial metrics. The company also increased its share repurchase expectations to up to $1 billion by year-end.
2026-08
Pulse 2.0
Zimmer Biomet: Technology And Data Sales Jump 21.5% As Knee Sales Stay Nearly Flat And 2026 Buybacks Target Up To $1 Billion
Zimmer Biomet's Technology & Data, Bone Cement, and Surgical product category saw a 21.5% increase in second-quarter 2026 sales on a constant-currency basis, making it the fastest-growing major product group. The company also increased its target for common stock repurchases to as much as $1 billion for 2026.
2026-08
Zimmer Biomet Stories
New Study Shows AI-Driven Diagnostic Significantly Improves Certainty, Reduces Costs in Detecting Joint Replacement Infections
A new study indicates that an AI-driven diagnostic tool significantly enhances the certainty and reduces costs associated with detecting joint replacement infections. This highlights Zimmer Biomet's focus on leveraging AI in healthcare.
2026-02
Zimmer Biomet Investor Relations
Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSAu00ae Knee Robotic Technology
Zimmer Biomet received U.S. FDA 510(k) clearance for ROSAu00ae Knee with OptimiZeu2122, an enhanced version of its robotic ROSAu00ae Knee System. This upgrade aims to provide surgeons with a more personalized and consistent approach to robotic-assisted total knee replacement.
2025-11
Zimmer Biomet Investor Relations
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
Zimmer Biomet announced that its first-to-world iodine-treated total hip replacement system has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This marks the first time a Zimmer Biomet product has received this designation.
2025-10
News at IU
Indiana University and Zimmer Biomet launch research, workforce partnership
Indiana University and Zimmer Biomet have initiated a partnership focused on research and workforce development. This collaboration aims to advance innovation and talent in the healthcare sector.
2026-04

Frequently Asked Questions

Zimmer Biomet offers a comprehensive suite of AI-powered solutions under its ZBEdge platform, including robotic systems like ROSA Knee, Hip, and Shoulder for precise surgical planning and execution. For post-operative care, solutions like mymobility and WalkAI leverage AI to monitor patient recovery and predict gait speed outcomes, while Persona IQ is the world's first smart knee implant that wirelessly transmits gait data. Additionally, OrthoGrid Hip AI and Trauma AI provide intra-operative guidance and image analysis, and Omni Suite uses AI to optimize operating room workflow efficiency.
Zimmer Biomet prioritizes patient data privacy and security by implementing robust safeguards such as encryption for data in transit and at rest, scheduled security risk assessments, and third-party penetration testing. They adhere to a 'minimum necessary' approach for Protected Health Information (PHI) and establish strong identity controls, including multi-factor authentication and role-based privileges. Many of their AI-enabled devices, such as the ROSA Knee with OptimiZe and Persona IQ smart knee implant, have received FDA clearances, and they engage in Business Associate Agreements (BAAs) with healthcare providers to ensure shared HIPAA compliance.
While specific pricing structures for individual AI-enabled technologies are not publicly detailed, Zimmer Biomet's market approach is evolving to address value and cost-effectiveness, particularly with the shift towards Ambulatory Surgical Centers (ASCs). Their partnership with RevelAi Health explicitly focuses on commercializing generative AI solutions for value-based orthopedic care. This indicates a strategic alignment towards models that emphasize value and outcomes, though explicit subscription or value-based purchasing options for all AI platforms are not broadly disclosed.
Zimmer Biomet offers comprehensive technical support through dedicated teams for various products like mymobility and OrthoGrid, along with general customer service. For training, they provide an interactive learning environment via the Zimmer Biomet Institute, which includes in-person courses, digital events, surgeon-to-surgeon experiences, and virtual reality offerings. Their ZBEdge ecosystem is designed for integration, and collaborations like the one with Microsoft Azure highlight efforts to build scalable and secure AI solutions that integrate with existing IT infrastructure.
Yes, Zimmer Biomet actively pursues strategic partnerships to advance its AI capabilities. Notable collaborations include a multi-year co-marketing agreement with RevelAi Health for generative AI solutions in value-based care and a three-year project with the Hospital for Special Surgery (HSS) to co-develop AI-powered decision support tools for joint replacements. They also leverage Microsoft Azure for their internal AI framework, collaborate with Peritas AI Inc. on agentic connected robotics, and have partnered with Canary Medical for the Persona IQ smart knee implant.
Zimmer Biomet is committed to creating clinically validated decision support tools and supports its technology with evidence from studies. Products like the ROSA Knee system have demonstrated improved accuracy and outcomes in clinical studies, and OrthoGrid Hip AI has shown comparable accuracy to human-controlled methods. Their AI models, such as WalkAI, are built from extensive anonymized real-world data to deliver actionable predictions, and many of their AI-enabled devices undergo rigorous regulatory processes, securing FDA clearances before market release.
Zimmer Biomet's long-term vision is to transform the patient experience through innovative products and integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence. They are making significant investments in AI and autonomous robotics, as evidenced by their acquisition of Monogram Technologies Inc. and ongoing R&D, to enhance surgical efficiency and patient outcomes. Their ZBEdge platform acts as an 'Agentic AI layer' to connect data across the patient journey, ensuring continuous evolution and sustainability of their AI product portfolio through a relentless focus on innovation and strategic growth.

Related Companies

QuickIntell
Chicago, IL, USA

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief
Kulpsville, PA

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed (Niedersächsisches Zentrum für KI und Kausale Methoden in der Medizin)
Hannover, Germany (Lower Saxony region)

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm
Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA
London, UK

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
London, United Kingdom

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.